Determined to boost its export potential, the Saint Petersburg SRI of Vaccines and Serums of the FMBA, in June 2018, successfully passed an audit for the compliance of antigen production for influenza vaccine conducted by specialists from the Food and Drug Administration of the Islamic Republic of Iran.
In August, the SPbSRIVS received the corresponding certificate confirming the full compliance of its production with GMP requirements.
